Aspalatone

N/A

Report date: 2023/02/11 20:37:38
NME

Base Information

Drug NameAspalatone
Drug Alias NameasparatoneBK-111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet aggregation inhibitors
TargetsUpdating
Therapy Area/IndicationsThrombosisAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBukwang Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBukwang Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsThrombosisAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A